Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

Inhaled corticosteroids in chronic obstructive pulmonary disease: a pro-con perspective.

Babu KS, Kastelik JA, Morjaria JB.

Br J Clin Pharmacol. 2014 Aug;78(2):282-300. doi: 10.1111/bcp.12334. Review.

2.

Influencing the decline of lung function in COPD: use of pharmacotherapy.

Gladysheva ES, Malhotra A, Owens RL.

Int J Chron Obstruct Pulmon Dis. 2010 Jun 3;5:153-64. Review.

3.

Patient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat Soft Mist inhaler.

Hodder R, Price D.

Int J Chron Obstruct Pulmon Dis. 2009;4:381-90. Epub 2009 Oct 19. Review.

4.

Insights into interventions in managing COPD patients: lessons from the TORCH and UPLIFT studies.

Miravitlles M, Anzueto A.

Int J Chron Obstruct Pulmon Dis. 2009;4:185-201. Epub 2009 May 7. Review.

5.

Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis.

Drummond MB, Dasenbrook EC, Pitz MW, Murphy DJ, Fan E.

JAMA. 2008 Nov 26;300(20):2407-16. doi: 10.1001/jama.2008.717. Review. Erratum in: JAMA. 2009 Mar 11;301(10):1024.

Supplemental Content

Support Center